Skip to content
IMExaminer
IMExaminer
Toggle sidebar

HHS Resuscitation: Why a Rising Sodium Is Not a Fluid Order

A rising sodium can be expected as glucose falls in HHS. Learn why serial osmolality, perfusion, fluid balance, and cardiac risk—not one lab value—should guide fluid changes.

IMExaminer Medical reviewer: Dr. Ali Ragab, MBBCH, MSc, MCAI 6 min read
Editorial illustration of IV fluids and laboratory vials beside an abstract trend chart, representing serial osmolality monitoring during HHS treatment.

A rising measured sodium during HHS treatment can be mistaken for worsening dysnatremia just as the patient is beginning to improve. In an older adult who is hypotensive and may have cardiac ischemia, a reflex switch to half-normal saline can misread the physiology; stopping needed fluids can leave poor perfusion untreated. The more useful question is: when should a sodium rise change the next fluid order?

Consider this illustrative case of a hyperosmolar hyperglycemic presentation, not a fully documented diagnosis: a 78-year-old woman with three days of poor intake and lethargy, blood pressure 95/60 mmHg, tachycardia, dry mucous membranes, glucose 850 mg/dL, sodium 132 mmol/L, BUN 65 mg/dL, pH 7.38, and bicarbonate 24 mmol/L. Her glucose, calculated osmolality, pH, and bicarbonate meet the corresponding hyperglycemia, hyperosmolarity, and no-acidosis components of current HHS criteria. However, no ketone result is provided, so HHS is not fully established from this vignette and mixed DKA/HHS cannot be excluded. ECG abnormalities and an elevated troponin raise concern for a cardiac precipitant, but the cardiac diagnosis and her ability to tolerate fluid are not established by those findings alone. Her baseline cognition, prior creatinine, urine output, heart-failure history, and usual function are also missing. Those details matter to reassessment; they are not reasons to delay treatment of hypovolemia.

Reconcile the osmolality before following it

For hyperglycemia, calculate effective osmolality with the measured sodium: approximately 2 × Na + glucose/18, with sodium in mmol/L and glucose in mg/dL. A total calculated osmolality adds BUN/2.8 when BUN is in mg/dL. Effective osmolality estimates tonicity; urea contributes to total osmolality but is not included in that effective calculation.

With the values above, effective osmolality is about 311 mOsm/kg: 2 × 132 + 850/18. Total calculated osmolality is about 334 mOsm/kg after adding 65/2.8. If the vignette separately reports an osmolality of 345 mOsm/kg, determine whether it was directly measured or calculated. A directly measured result need not exactly match the calculated estimate; if 345 is said to be calculated, recheck the inputs, units, and formula. Use serial results obtained consistently and document the method when interpreting a trend. Both calculations from the listed values exceed the current hyperosmolarity threshold, but a mismatch still matters when comparing later results.

A corrected sodium near 144 mmol/L using the common 1.6 mmol/L correction per 100 mg/dL glucose above 100 may help estimate the water deficit. It is an estimate, not the patient’s current measured sodium and not a fluid prescription.

Why sodium may rise as HHS improves

Severe hyperglycemia pulls water from cells into the extracellular space, lowering the measured sodium concentration. As fluids—and, when used, insulin—lower glucose, some water shifts back into cells. Measured sodium can therefore rise even while osmolality falls. A sodium increase of about 1.6 mmol/L for each 100 mg/dL fall in glucose is a useful expectation, not a rigid rule for every patient.

The important distinction is between a rising sodium with falling osmolality and a rising sodium with stagnant or increasing osmolality. The first may be an expected part of correction. The second calls for a closer look at volume replacement, ongoing losses, insulin timing, and the accuracy and timing of the laboratory samples.

Let the trend—not sodium alone—guide the next bag

Follow glucose frequently and compare sodium, kidney function, fluid input and output, clinical perfusion, and osmolality over time. Current guidance recommends regular repeat assessment during treatment; the 2026 ADA hospital standards describe checking electrolytes, kidney function, venous pH, osmolality, and glucose every 2–4 hours until stable. A 2024 multi-society consensus gives a working osmolality decline range of 3–8 mOsm/kg/hour, advises that glucose fall not exceed 90–120 mg/dL/hour, and recommends that sodium decline not exceed 10 mmol/L in 24 hours. Published targets are not fully harmonized, and HHS-specific evidence is limited, so use the local protocol rather than treating a number as a universal fluid order.

Pattern during treatment How to interpret it Practical response
Sodium rises, glucose falls, osmolality falls at the protocol’s intended pace, and perfusion improves without congestion Often an expected treatment trajectory Do not switch fluids on sodium alone; continue close reassessment.
Osmolality is flat or rising, with ongoing negative fluid balance or poor perfusion and no evidence of overload Possible inadequate replacement or continuing losses Check the delivered fluid, urine output, and losses; adjust isotonic fluid to the clinical picture and local pathway.
Osmolality is not declining despite adequate positive fluid balance and appropriate insulin Sodium alone still does not settle the choice A switch to 0.45% saline may be considered under the treatment pathway, with continued monitoring.
Osmolality is falling too quickly, mental status worsens, or congestion develops The correction or fluid tolerance needs urgent reassessment Review fluid and insulin rates; assess neurologic, cardiac, and renal status rather than blindly continuing or switching fluids.

Resuscitate an older patient without using a fixed-volume reflex

Her low blood pressure and tachycardia make restoration of perfusion important. Her age and possible cardiac disease make frequent reassessment equally important. In older adults—and in people with heart failure or end-stage kidney disease on dialysis—guidance supports smaller crystalloid boluses, such as 250 mL, with repeated assessment rather than an automatic large-volume schedule.

After each increment, reassess blood pressure, heart rate, peripheral perfusion, urine output, oxygenation, lung findings, and signs of venous congestion. If pulmonary congestion or worsening oxygenation appears, do not keep escalating fluid because the sodium is rising. Reassess cardiac and renal function and involve the appropriate acute-care team. The ECG and troponin warrant parallel evaluation as a possible precipitant; neither should replace bedside assessment of fluid response.

Common traps on rounds

  • Calling 132 mmol/L true hypotonic hyponatremia: Severe hyperglycemia shifts water and lowers the measured sodium.
  • Treating corrected sodium as the next-fluid selector: It estimates a sodium value at a different glucose level; it does not replace the serial osmolality and volume assessment.
  • Switching to half-normal saline because sodium rose: First establish whether osmolality is falling and whether fluid balance and perfusion are adequate.
  • Trusting an unreconciled osmolality: Confirm units, sample timing, and whether the result was measured or calculated before interpreting the trend.

Practical takeaways

  • In HHS, a rising measured sodium can accompany falling glucose and improving osmolality.
  • Follow sodium with glucose, osmolality, perfusion, urine output, and fluid balance—not as an isolated trigger.
  • Consider hypotonic fluid only when the overall trajectory and local protocol support it; a sodium rise alone is not enough.
  • In older adults or patients with cardiac or renal risk, individualize fluid increments and reassess frequently.

Frequently asked questions

Keep learning

Case Discussion

Pancreatitis With Gallstones and TG 1,250: Is Plasma Exchange Needed?

When gallstones and triglycerides near 1,250 mg/dL coexist, the triglyceride result supports a possible contributor—not an automatic insulin drip or plasma-exchange order. Separate cause from treatment, and assess for biliary obstruction.

Case Discussion

Esophageal Cancer Work-up on Warfarin: Biopsy vs EUS-FNA

For progressive dysphagia in a patient with a mechanical mitral valve, distinguish diagnostic biopsy from EUS-guided sampling before deciding whether to interrupt warfarin.

Case Discussion

Cirrhotic Variceal Bleeding: Should INR and Platelets Be Corrected?

With suspected variceal bleeding, an INR of 1.8 and platelets of 45,000/µL can trigger reflex transfusions. Learn why those results alone should not delay endoscopic hemostasis.

We use cookies to enhance your experience. By clicking Accept, you agree to all analytics and advertising cookies. Terms of Use & Privacy Policy